RCMC
INFI

Rubric Capital Management (Connecticut)’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Rubric Capital Management (Connecticut)’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-125,000
Closed -$981K – 31
2015
Q4 		$981K Buy
+125,000
New +$1.08M 0.09% 52

Other funds holding INFI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Rubric Capital Management (Connecticut)'s INFI Position: Q1 2016 in Review

Rubric Capital Management (Connecticut) sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2016, closing a stake of 125,000 shares — an estimated $981K sold.

Rubric Capital Management (Connecticut) first reported a position in INFI in Q4 2015 and held it in 1 quarter. The position peaked at $981K in Q4 2015. 117 funds tracked by Wall St. Rank hold INFI as of Q1 2016.

  • Rubric Capital Management (Connecticut) reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Rubric Capital Management (Connecticut) sold 125,000 Infinity Pharmaceuticals, Inc. shares in Q1 2016, an estimated $981K.
  • Rubric Capital Management (Connecticut) first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2015 and held it in 1 quarter.
  • Rubric Capital Management (Connecticut)'s Infinity Pharmaceuticals, Inc. position peaked at $981K in Q4 2015.
  • 117 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2016.

Based on Rubric Capital Management (Connecticut)'s 13F filing for Q1 2016, filed 16 May 2016.